Overview
This is a cohort study performed in patients with cardiovascular diaeases who were treated with oral Chinese medicine and Western medicine. Collect indicators such as the incidence of cardiovascular events, all due to readmission, all due to death. To hospital using clinical samples to detect genomics, proteomics, metabolomics, intestinal flora and sclerotia.To explore the clinical efficacy of Chinese patent medicine in the treatment of cardiovascular diseases, and provide reliable data support for its clinical application.
Eligibility
Inclusion Criteria:
All patients admitted to the Department of Cardiovascular Medicine at The First Teaching
Hospital of Tianjin University of Traditional Chinese Medicine, The Second Teaching
Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin Chest Hospital,
Tianjin Hospital of ITCWM Nankai Hospital and Tianjin Academy of Traditional Chinese
Medicine Affiliated Hospital were considered for inclusion in this study, and all Western
medical diagnoses were identified and classified according to the International
Classification of Diseases, 11th Revision (ICD-11).
Exclusion Criteria:
No exclusion criteria.